Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection

Annals of Internal Medicine

Volumn 133, Issue 6, 2000, Pages

  Colven, R ^a   Harrington, R D ^a   Spach, D H ^a   Cohen, C J ^a   Hooton, T M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; INDINAVIR; LAMIVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CELL COUNT; CLINICAL FEATURE; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; REBOUND; SERODIAGNOSIS; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0034687138     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-6-200009190-00010     Document Type: Article

References (10)

1. Clinical and epidemiologic features of primary HIV infection
2. Acute primary HIV infection
3. Acute human immunodeficiency virus type 1 infection
4. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy
5. Rebound of plasma HIV viral load following prolonged suppression with combination therapy
6. Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy
7. Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion
8. Primary human immunodeficiency virus type 1 infection: Review of pathogenesis and early treatment intervention in humans and animal retrovirus infections
9. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
10. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection